MARKET

CORT

CORT

Corcept Therapeutics Inc
NASDAQ
118.51
+5.57
+4.93%
After Hours: 118.00 -0.51 -0.43% 17:59 09/24 EDT
OPEN
111.86
PREV CLOSE
112.94
HIGH
119.15
LOW
111.68
VOLUME
983.62K
TURNOVER
--
52 WEEK HIGH
126.38
52 WEEK LOW
28.66
MARKET CAP
12.81B
P/E (TTM)
278.13
1D
5D
1M
3M
1Y
5Y
1D
Corcept Therapeutics Announces New Endocrinology Division President
TipRanks · 1d ago
Corcept Therapeutics president of endocrinology Sean Maduck to retire
TipRanks · 1d ago
*Corcept Therapeutics: Justin Gunn to Succeed Maduck, Assume New Responsibilities Starting Oct 1 >CORT
Dow Jones · 1d ago
*Corcept Therapeutics Announces Retirement of Sean Maduck, Pres Its Endocrinology Division
Dow Jones · 1d ago
IJR, CORT, VSAT, GKOS: Large Inflows Detected at ETF
NASDAQ · 2d ago
3 of Wall Street’s Favorite Stocks We Keep Off Our Radar
Barchart · 2d ago
Weekly Report: what happened at CORT last week (0914-0918)?
Weekly Report · 3d ago
3 things to look out for on Monday
Seeking Alpha · 6d ago
More
About CORT
Corcept Therapeutics Incorporated is a commercial-stage company. The Company is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. It is also conducting advanced clinical trials in patients with solid tumors, Amyotrophic Lateral Sclerosis (ALS) and liver disease. It operates through the discovery, development and commercialization of the pharmaceutical products segment. It sells Korlym and a generic version of Korlym in the United States using sales representatives to call on physicians caring for patients with hypercortisolism (Cushing’s syndrome). The Company's portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. It sells and distributes Lifyorli in the United States. It is developing its proprietary, selective cortisol modulator, relacorilant, as a treatment for patients with hypercortisolism.

Webull offers Corcept Therapeutics Inc stock information, including NASDAQ: CORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CORT stock methods without spending real money on the virtual paper trading platform.